Related Experiment Videos
Frontal atrophy correlates with behavioural changes in progressive supranuclear palsy.
N J Cordato1, C Pantelis, G M Halliday
1Department of Neurology, Westmead Hospital, Westmead, NSW 2145, Australia. ncordato@mail.usyd.edu.au
Brain : a Journal of Neurology
|March 26, 2002
Summary
Progressive supranuclear palsy (PSP) is distinguished from Parkinson's disease by significant whole brain volume loss and frontal cortex atrophy. These brain atrophy patterns aid in differentiating PSP from Parkinson's disease radiologically.
Area of Science:
- Neuroimaging
- Neurology
- Radiology
Background:
- Progressive supranuclear palsy (PSP) and Parkinson's disease (PD) are neurodegenerative disorders with overlapping clinical symptoms.
- Accurate radiological differentiation between PSP and PD is crucial for diagnosis and management.
Purpose of the Study:
- To investigate regional brain volume differences between PSP, PD, and healthy controls.
- To identify MRI-based biomarkers for distinguishing PSP from PD.
Main Methods:
- 3D MRI-based volumetry was used to measure regional brain volumes in 21 PSP patients, 17 PD patients, and 23 controls.
- Brain volumes were correlated with motor disability and cognitive disturbance indices.
Main Results:
- Parkinson's disease patients showed preserved MRI measures, including hippocampal volume.
- PSP patients exhibited whole brain volume loss, ventricular dilatation, and disproportionate frontal cortex atrophy compared to PD and controls.
- Caudate nucleus volume loss was observed in PSP, differentiating them from controls, but was modest and proportional to whole brain volume loss.
Conclusions:
- Distinct patterns of brain atrophy differentiate PSP from PD, offering potential for in vivo radiological differentiation.
- Frontal grey matter volume loss in PSP correlates with behavioral disturbances, suggesting intrinsic cortical deficits contribute to clinical symptoms.